We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
+16.6%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
–
AUM
$234M
AUM Growth
+$9.93M
Cap. Flow
-$25.9M
Cap. Flow %
-11.05%
Top 10 Hldgs %
18.52%
Holding
269
New
36
Increased
60
Reduced
141
Closed
17

Top Buys

Rank Stock Value
1
SBRA icon
Sabra Healthcare REIT
SBRA
+$1.83M
2
VTC icon
Vanguard Total Corporate Bond ETF
VTC
+$1.72M
3
FHI icon
Federated Hermes
FHI
+$1.53M
4
INVA icon
Innoviva
INVA
+$1.09M
5
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$1.07M

Top Sells

Rank Stock Value
1
IJK icon
iShares S&P Mid-Cap 400 Growth ETF
IJK
+$7.45M
2
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4.57M
3
CXSE icon
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
+$2.35M
4
VER
VEREIT, Inc.
VER
+$2.1M
5
PFG icon
Principal Financial Group
PFG
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 12.59%
2 Financials 8.72%
3 Healthcare 7.69%
4 Communication Services 7.5%
5 Consumer Discretionary 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
226
BioCryst Pharmaceuticals
BCRX
$2.28B
$177K 0.08%
23,800
-1,000
-4% -$5.16K
GE icon
227
GE Aerospace
GE
$374B
$168K 0.07%
3,020
+1
+0% +$45
NNDM
228
Nano Dimension
NNDM
$316M
$161K 0.07%
+17,750
New +$90K
PRTK
229
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$138K 0.06%
22,050
-2,500
-10% -$14.7K
KGC icon
230
Kinross Gold
KGC
$27.4B
$116K 0.05%
15,846
+787
+5% +$6.27K
CLVS
231
DELISTED
Clovis Oncology, Inc.
CLVS
$114K 0.05%
23,750
-500
-2% -$2.53K
GYRE icon
232
Gyre Therapeutics
GYRE
$641M
$112K 0.05%
2,375
– –
NLY icon
233
Annaly Capital Management
NLY
$17.1B
$112K 0.05%
3,297
-26
-0.8% -$805
CTEV
234
Claritev Corp
CTEV
$387M
$104K 0.04%
+326
New +$109K
PSLV icon
235
Sprott Physical Silver Trust
PSLV
$12B
$94K 0.04%
10,062
– –
APTS
236
DELISTED
Preferred Apartment Communities, Inc.
APTS
$89K 0.04%
11,788
-2,039
-15% -$13.9K
OXLC
237
Oxford Lane Capital
OXLC
$894M
$78K 0.03%
2,890
+325
+13% +$8.01K
AMRN
238
Amarin Corp
AMRN
$299M
$77K 0.03%
788
-115
-13% -$11.1K
DBRG icon
239
DigitalBridge
DBRG
$2.93B
$61K 0.03%
2,991
-355
-11% -$5.68K
AGRX
240
DELISTED
Agile Therapeutics
AGRX
$55K 0.02%
10
– –
VSTM icon
241
Verastem
VSTM
$510M
$53K 0.02%
2,104
-334
-14% -$6.71K
SNMP
242
DELISTED
Evolve Transition Infrastructure LP
SNMP
$33K 0.01%
701
– –
ABT icon
243
Abbott
ABT
$183B
– –
-2,351
Closed -$259K
CORP icon
244
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.57B
– –
-4,417
Closed -$507K
CTSO icon
245
Cytosorbents Corp
CTSO
$22.7M
– –
-12,150
Closed -$97K
DGRW icon
246
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
– –
-9,235
Closed -$479K
IPKW icon
247
Invesco International BuyBack Achievers ETF
IPKW
$551M
– –
-6,738
Closed -$211K
ITOT icon
248
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
– –
-10,532
Closed -$850K
MTUM icon
249
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
– –
-1,437
Closed -$212K
NVS icon
250
Novartis
NVS
$297B
– –
-3,540
Closed -$299K
7 8 9
10
11

Similar funds

IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
UCIG
Ulrich Consultants & Investment Group Albuquerque, New Mexico $41.4M AUM 20.81% 1-Year Est. Return
KP
Kuvari Partners London, United Kingdom $52.2M AUM
NH
NNS Holding Camana Bay, Grand Cayman, Cayman Islands $53.2M AUM
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
VCM
Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return
FGIM
First Growth Investment Manager San Francisco, California $59.5M AUM 30.53% 1-Year Est. Return
WGRM
Waterton Global Resource Management Toronto, Ontario, Canada $64.9M AUM 17.81% 1-Year Est. Return

Kalos Management's Q4 2020 Portfolio in Review

As of Q4 2020, Kalos Management held 269 positions worth $234M, up 4.4% from $224M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Kalos Management withdrew a net $25.9M in Q4 2020, closing 17 positions and reducing 141 holdings. Its most notable exit was Principal Financial Group, an estimated $1.91M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Kalos Management opened a new position in Sabra Healthcare REIT worth $2.07M.

  • Kalos Management's largest Q4 2020 buy was Sabra Healthcare REIT: 114,870 shares worth $2.07M.
  • Kalos Management added most to Vanguard Total Corporate Bond ETF in Q4 2020, an estimated $1.72M increase.
  • Kalos Management's biggest Q4 2020 reduction was iShares S&P Mid-Cap 400 Growth ETF, cutting an estimated $7.45M.
  • Kalos Management fully exited Principal Financial Group in Q4 2020, selling an estimated $1.91M.
  • Kalos Management's ten largest holdings make up 19% of its $234M portfolio in Q4 2020.
  • Kalos Management opened 36 new positions and closed 17 in Q4 2020.
  • Kalos Management's portfolio value rose 4.4% quarter-over-quarter to $234M.

Based on Kalos Management's 13F filing for Q4 2020, filed 11 Feb 2021.